• Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1 1
    Poland Spain
  • Study of Pembrolizumab and Lenvatinib for Patients with Resectable Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study on the Effectiveness of Sphenopalatine Ganglion Block vs. Scalp Block in Patients Undergoing Craniotomy for Supratentorial Mass Using Levobupivacaine and Drug Combination

    Recruiting

    3 1 1
    Belgium
  • Study of Autologous Microfat and Platelet-Rich Plasma Injection Compared to Wrist Denervation in Patients with Radiocarpal Osteoarthritis

    Recruiting

    2 1 1
    Investigated diseases:
    France
  • Study of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis

    Recruiting

    3 1 1
    Czechia Denmark France Greece Hungary Poland +1
  • Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Norway +1
  • Study on Amoxicillin and Clavulanic Acid for Treating Ventilator-Associated Pneumonia in Intensive Care Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on the Safety and Effects of Regadenoson and Gadobutrol in Heart Imaging for Children with Cardiovascular Conditions

    Recruiting

    1 1 1 1
    Investigated drugs:
    France Greece Italy
  • Study on Reducing HIV Latent Reservoirs Using High Doses of Lamivudine, Maraviroc, and Dolutegravir Sodium for Patients with HIV Infection

    Recruiting

    2 1 1 1
    Investigated diseases:
    Spain

powered by